231 related articles for article (PubMed ID: 26952299)
1. Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma.
Moon Y; Kim KS; Lee KY; Sung SW; Kim YK; Park JK
Ann Thorac Surg; 2016 May; 101(5):1928-35. PubMed ID: 26952299
[TBL] [Abstract][Full Text] [Related]
2. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
[TBL] [Abstract][Full Text] [Related]
3. [Risk Factors of Nodal Upstaging in Clinical Ia Lung Adenocarcinoma].
Qin Y; Qiu T; Xuan Y; Zhao Y; Jiao W
Zhongguo Fei Ai Za Zhi; 2018 Jun; 21(6):463-469. PubMed ID: 29945705
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less.
Moon Y; Choi SY; Park JK; Lee KY
World J Surg; 2020 May; 44(5):1658-1665. PubMed ID: 31912252
[TBL] [Abstract][Full Text] [Related]
5. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
[TBL] [Abstract][Full Text] [Related]
6. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.
Yeh YC; Kadota K; Nitadori J; Sima CS; Rizk NP; Jones DR; Travis WD; Adusumilli PS
Eur J Cardiothorac Surg; 2016 Jan; 49(1):e9-e15. PubMed ID: 26377636
[TBL] [Abstract][Full Text] [Related]
7. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
[No Abstract] [Full Text] [Related]
8. Factors associated with lymph node metastasis upstage after resection for patients with micropapillary lung adenocarcinoma.
Matsushima K; Sonoda D; Mitsui A; Tamagawa S; Hayashi S; Naito M; Matsui Y; Shiomi K; Satoh Y
Thorac Cancer; 2022 Jan; 13(1):48-53. PubMed ID: 34866323
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Occult Lymph Node Metastasis Using Tumor-to-Blood Standardized Uptake Ratio and Metabolic Parameters in Clinical N0 Lung Adenocarcinoma.
Ouyang ML; Tang K; Xu MM; Lin J; Li TC; Zheng XW
Clin Nucl Med; 2018 Oct; 43(10):715-720. PubMed ID: 30106864
[TBL] [Abstract][Full Text] [Related]
10. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma.
Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Kobayashi T; Uno K
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):396-401. PubMed ID: 15354098
[TBL] [Abstract][Full Text] [Related]
11. Consolidation/Tumor Ratio on Chest Computed Tomography as Predictor of Postoperative Nodal Upstaging in Clinical T1N0 Lung Cancer.
Moon Y; Park JK; Lee KY; Namkoong M; Ahn S
World J Surg; 2018 Sep; 42(9):2872-2878. PubMed ID: 29450699
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.
Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Ardissone F; Pelosi E
Eur J Cardiothorac Surg; 2013 Mar; 43(3):574-9. PubMed ID: 22689182
[TBL] [Abstract][Full Text] [Related]
13. Utility of mediastinoscopy in clinical stage I lung cancers at risk for occult mediastinal nodal metastases.
Fernandez FG; Kozower BD; Crabtree TD; Force SD; Lau C; Pickens A; Krupnick AS; Veeramachaneni N; Patterson GA; Jones DR; Meyers BF
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):35-41, 42.e1. PubMed ID: 25439769
[TBL] [Abstract][Full Text] [Related]
14. Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis.
Chang C; Sun X; Zhao W; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Xie W; Shen J
Radiol Med; 2020 Mar; 125(3):257-264. PubMed ID: 31823295
[TBL] [Abstract][Full Text] [Related]
15. Programmed death ligand-1 expression and occult lymph node metastasis in non-small cell lung cancer.
Mitsui S; Tanaka Y; Jimbo N; Doi T; Tane S; Hokka D; Maniwa Y
Thorac Cancer; 2023 Jun; 14(18):1774-1781. PubMed ID: 37160414
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Characteristics of Lung Adenocarcinoma with Unexpected Lymph Node Metastasis.
Haruki T; Wakahara M; Matsuoka Y; Miwa K; Araki K; Taniguchi Y; Nakamura H
Ann Thorac Cardiovasc Surg; 2017 Aug; 23(4):181-187. PubMed ID: 28539542
[TBL] [Abstract][Full Text] [Related]
17. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
[TBL] [Abstract][Full Text] [Related]
18. Presence of micropapillary and solid patterns are associated with nodal upstaging and unfavorable prognosis among patient with cT1N0M0 lung adenocarcinoma: a large-scale analysis.
Yuan Y; Ma G; Zhang Y; Chen H
J Cancer Res Clin Oncol; 2018 Apr; 144(4):743-749. PubMed ID: 29392402
[TBL] [Abstract][Full Text] [Related]
19. F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma.
Noda Y; Goshima S; Kanematsu M; Watanabe H; Kawada H; Kawai N; Ono H; Bae KT
Ann Nucl Med; 2016 Jan; 30(1):11-7. PubMed ID: 26337532
[TBL] [Abstract][Full Text] [Related]
20. Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?
Decaluwé H; Moons J; Fieuws S; De Wever W; Deroose C; Stanzi A; Depypere L; Nackaerts K; Coolen J; Lambrecht M; Verbeken E; De Ruysscher D; Vansteenkiste J; Van Raemdonck D; De Leyn P; Dooms C;
Eur J Cardiothorac Surg; 2018 Jul; 54(1):134-140. PubMed ID: 29447330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
